Christopher e Hopkins
Chief Executive Officer @Glafabra Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer @Glafabra Therapeutics
At Glafabra Therapeutics we are building durable cell therapies for enzyme deficiency disorders that effect 80M patients worldwide. Our lead asset GT-GLA-S03 is in Fabry disease ant its therapeutic durability is now well documented in publications of Canadian clinical trials. Other diseases targets in metabolic disorders are under development using our STEM, TRAM and iTRAM technologies.
EDUCATION
University of Utah
BS, Biology
Boston University
Ph. D., Molecular-Cellular Biology and Biochemistry
Westminster University
Master of Business Administration (MBA), Project-based degree
SKILLS
ABOUT CHRISTOPHER E HOPKINS
Chris is bringing to market a cell-based gene therapy to help patients with Fabry, Pompe…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.